世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
次世代婦人科がん診断薬の世界市場レポート 2023年以下を含む：1) 癌タイプ別がんタイプ別：子宮頸がん、卵巣がん、子宮体がん、膣がん、外陰がん2）機能別：治療モニタリング、コンパニオン診断、予後診断、がんスクリーニング、リスク分析機能別：治療モニタリング、コンパニオン診断薬、予後診断薬、がんスクリーニング、リスク分析3）技術別次世代シーケンシング、qPCRとマルチプレキシング、ラボオンチップ（LOAC）と逆転写酵素PCR（RT-PCR）、タンパク質マイクロアレイ、DNAマイクロアレイ4) アプリケーション別：バイオマーカー開発、CTC解析、プロテオーム解析、エピジェネティック解析、遺伝子解析5) エンドユーザー別：病院・外来センター、診断研究所、学術・研究機関Covering：エフ・ホフマン・ラ・ロシュ社、アッヴィ社、ノバルティス社、サーモフィッシャーサイエンティフィック社、アボットラボラトリーズ社Next-Generation Gynecological Cancer Diagnostics Global Market Report 2023Including: 1) By Cancer Type: Cervical Cancer; Ovarian Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer2) By Function: Therapeutic Monitoring; Companion Diagnostics; Prognostics; Cancer Screening; Risk Analysis3) By Technology: Next-Generation Sequencing; qPCR And Multiplexing; Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR); Protein Microarrays; DNA Microarrays4) By Application: Biomarker Development; CTC Analysis; Proteomic Analysis; Epigenetic Analysis; Genetic Analysis5) By End User: Hospitals and Ambulatory Centers; Diagnostic Laboratories; Academic and Research InstitutesCovering: F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Novartis AG; Thermo Fisher Scientific Inc.; Abbott Laboratories The Business Research Companyの次世代婦人科癌診断薬の世界市場レポート2023は、戦略担当者、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。 このレポートは、力強い... もっと見る
サマリーThe Business Research Companyの次世代婦人科癌診断薬の世界市場レポート2023は、戦略担当者、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。このレポートは、力強い成長を遂げている次世代婦人科がん診断薬市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドの指針を示します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真のグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3～5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 次世代婦人科がん診断薬の最大かつ最速の成長市場はどこか？経済全体、人口動態、他の類似市場との関連は？今後どのような力が市場を形成していくのか？ビジネスリサーチ社の次世代婦人科がん診断薬世界市場レポートでは、これらすべての疑問やその他多くの疑問にお答えします。 本レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合環境、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場：1） 癌タイプ別子宮頸がん、卵巣がん、子宮体がん、膣がん、外陰がん 2) 機能別治療モニタリング、コンパニオン診断薬、予後診断薬、がんスクリーニング、リスク分析 3) 技術別次世代シーケンシング、qPCRおよびマルチプレキシング、ラボオンチップ（LOAC）および逆転写酵素PCR（RT-PCR）、タンパク質マイクロアレイ、DNAマイクロアレイ 4) アプリケーション別バイオマーカー開発；CTC解析；プロテオーム解析；エピジェネティック解析；遺伝子解析 5) エンドユーザー別：病院・外来センター、診断研究所、学術・研究機関 言及された企業エフ・ホフマン・ラ・ロシュ社、アッヴィ社、ノバルティス社、サーモフィッシャーサイエンティフィック社、アボットラボラトリーズ社 国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列：過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Next-Generation Gynecological Cancer Diagnostics Market Characteristics 3. Next-Generation Gynecological Cancer Diagnostics Market Trends And Strategies 4. Next-Generation Gynecological Cancer Diagnostics Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Next-Generation Gynecological Cancer Diagnostics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Next-Generation Gynecological Cancer Diagnostics Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Next-Generation Gynecological Cancer Diagnostics Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Next-Generation Gynecological Cancer Diagnostics Market Segmentation 6.1. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Cervical Cancer Ovarian Cancer Uterine Cancer Vaginal Cancer Vulvar Cancer 6.2. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Therapeutic Monitoring Companion Diagnostics Prognostics Cancer Screening Risk Analysis 6.3. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Next-Generation Sequencing qPCR And Multiplexing Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR) Protein Microarrays DNA Microarrays 6.4. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Biomarker Development CTC Analysis Proteomic Analysis Epigenetic Analysis Genetic Analysis 6.5. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospitals and Ambulatory Centers Diagnostic Laboratories Academic and Research Institutes 7. Next-Generation Gynecological Cancer Diagnostics Market Regional And Country Analysis 7.1. Global Next-Generation Gynecological Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Next-Generation Gynecological Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market 8.1. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Next-Generation Gynecological Cancer Diagnostics Market 9.1. China Next-Generation Gynecological Cancer Diagnostics Market Overview 9.2. China Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Next-Generation Gynecological Cancer Diagnostics Market 10.1. India Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Next-Generation Gynecological Cancer Diagnostics Market 11.1. Japan Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Next-Generation Gynecological Cancer Diagnostics Market 12.1. Australia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Next-Generation Gynecological Cancer Diagnostics Market 13.1. Indonesia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Next-Generation Gynecological Cancer Diagnostics Market 14.1. South Korea Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Next-Generation Gynecological Cancer Diagnostics Market 15.1. Western Europe Next-Generation Gynecological Cancer Diagnostics Market Overview 15.2. Western Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Next-Generation Gynecological Cancer Diagnostics Market 16.1. UK Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Next-Generation Gynecological Cancer Diagnostics Market 17.1. Germany Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Next-Generation Gynecological Cancer Diagnostics Market 18.1. France Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Next-Generation Gynecological Cancer Diagnostics Market 19.1. Italy Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Next-Generation Gynecological Cancer Diagnostics Market 20.1. Spain Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market 21.1. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market Overview 21.2. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Next-Generation Gynecological Cancer Diagnostics Market 22.1. Russia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Next-Generation Gynecological Cancer Diagnostics Market 23.1. North America Next-Generation Gynecological Cancer Diagnostics Market Overview 23.2. North America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Next-Generation Gynecological Cancer Diagnostics Market 24.1. USA Next-Generation Gynecological Cancer Diagnostics Market Overview 24.2. USA Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Next-Generation Gynecological Cancer Diagnostics Market 25.1. Canada Next-Generation Gynecological Cancer Diagnostics Market Overview 25.2. Canada Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Next-Generation Gynecological Cancer Diagnostics Market 26.1. South America Next-Generation Gynecological Cancer Diagnostics Market Overview 26.2. South America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Next-Generation Gynecological Cancer Diagnostics Market 27.1. Brazil Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Next-Generation Gynecological Cancer Diagnostics Market 28.1. Middle East Next-Generation Gynecological Cancer Diagnostics Market Overview 28.2. Middle East Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Next-Generation Gynecological Cancer Diagnostics Market 29.1. Africa Next-Generation Gynecological Cancer Diagnostics Market Overview 29.2. Africa Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Next-Generation Gynecological Cancer Diagnostics Market Competitive Landscape And Company Profiles 30.1. Next-Generation Gynecological Cancer Diagnostics Market Competitive Landscape 30.2. Next-Generation Gynecological Cancer Diagnostics Market Company Profiles 30.2.1. F. Hoffmann-La Roche Ltd. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. AbbVie Inc. 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Novartis AG 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Thermo Fisher Scientific Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Abbott Laboratories 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Next-Generation Gynecological Cancer Diagnostics Market Other Major And Innovative Companies 31.1. Janssen Global Services LLC 31.2. Siemens Healthcare GmbH 31.3. Agena Bioscience Inc. 31.4. Koninklijke Philips N.V. 31.5. Becton, Dickinson and Company 31.6. GE HealthCare Technologies Inc. 31.7. Laboratory Corporation Of America Holdings 31.8. Quest Diagnostics Incorporated 31.9. Agilent Technologies Inc. 31.10. Konica Minolta Inc. 31.11. Hologic Inc. 31.12. Illumina Inc. 31.13. PerkinElmer Inc. 31.14. Sysmex Corporation 31.15. Qiagen N.V. 32. Global Next-Generation Gynecological Cancer Diagnostics Market Competitive Benchmarking 33. Global Next-Generation Gynecological Cancer Diagnostics Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Next-Generation Gynecological Cancer Diagnostics Market 35. Next-Generation Gynecological Cancer Diagnostics Market Future Outlook and Potential Analysis 35.1 Next-Generation Gynecological Cancer Diagnostics Market In 2027 - Countries Offering Most New Opportunities 35.2 Next-Generation Gynecological Cancer Diagnostics Market In 2027 - Segments Offering Most New Opportunities 35.3 Next-Generation Gynecological Cancer Diagnostics Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryNext-Generation Gynecological Cancer Diagnostics Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Next-Generation Gynecological Cancer Diagnostics Market Characteristics 3. Next-Generation Gynecological Cancer Diagnostics Market Trends And Strategies 4. Next-Generation Gynecological Cancer Diagnostics Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Next-Generation Gynecological Cancer Diagnostics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Next-Generation Gynecological Cancer Diagnostics Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Next-Generation Gynecological Cancer Diagnostics Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Next-Generation Gynecological Cancer Diagnostics Market Segmentation 6.1. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Cervical Cancer Ovarian Cancer Uterine Cancer Vaginal Cancer Vulvar Cancer 6.2. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Therapeutic Monitoring Companion Diagnostics Prognostics Cancer Screening Risk Analysis 6.3. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Next-Generation Sequencing qPCR And Multiplexing Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR) Protein Microarrays DNA Microarrays 6.4. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Biomarker Development CTC Analysis Proteomic Analysis Epigenetic Analysis Genetic Analysis 6.5. Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospitals and Ambulatory Centers Diagnostic Laboratories Academic and Research Institutes 7. Next-Generation Gynecological Cancer Diagnostics Market Regional And Country Analysis 7.1. Global Next-Generation Gynecological Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Next-Generation Gynecological Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market 8.1. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Next-Generation Gynecological Cancer Diagnostics Market 9.1. China Next-Generation Gynecological Cancer Diagnostics Market Overview 9.2. China Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Next-Generation Gynecological Cancer Diagnostics Market 10.1. India Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Next-Generation Gynecological Cancer Diagnostics Market 11.1. Japan Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Next-Generation Gynecological Cancer Diagnostics Market 12.1. Australia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Next-Generation Gynecological Cancer Diagnostics Market 13.1. Indonesia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Next-Generation Gynecological Cancer Diagnostics Market 14.1. South Korea Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Next-Generation Gynecological Cancer Diagnostics Market 15.1. Western Europe Next-Generation Gynecological Cancer Diagnostics Market Overview 15.2. Western Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Next-Generation Gynecological Cancer Diagnostics Market 16.1. UK Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Next-Generation Gynecological Cancer Diagnostics Market 17.1. Germany Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Next-Generation Gynecological Cancer Diagnostics Market 18.1. France Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Next-Generation Gynecological Cancer Diagnostics Market 19.1. Italy Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Next-Generation Gynecological Cancer Diagnostics Market 20.1. Spain Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market 21.1. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market Overview 21.2. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Next-Generation Gynecological Cancer Diagnostics Market 22.1. Russia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Next-Generation Gynecological Cancer Diagnostics Market 23.1. North America Next-Generation Gynecological Cancer Diagnostics Market Overview 23.2. North America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Next-Generation Gynecological Cancer Diagnostics Market 24.1. USA Next-Generation Gynecological Cancer Diagnostics Market Overview 24.2. USA Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Next-Generation Gynecological Cancer Diagnostics Market 25.1. Canada Next-Generation Gynecological Cancer Diagnostics Market Overview 25.2. Canada Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Next-Generation Gynecological Cancer Diagnostics Market 26.1. South America Next-Generation Gynecological Cancer Diagnostics Market Overview 26.2. South America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Next-Generation Gynecological Cancer Diagnostics Market 27.1. Brazil Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Next-Generation Gynecological Cancer Diagnostics Market 28.1. Middle East Next-Generation Gynecological Cancer Diagnostics Market Overview 28.2. Middle East Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Next-Generation Gynecological Cancer Diagnostics Market 29.1. Africa Next-Generation Gynecological Cancer Diagnostics Market Overview 29.2. Africa Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Next-Generation Gynecological Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Next-Generation Gynecological Cancer Diagnostics Market Competitive Landscape And Company Profiles 30.1. Next-Generation Gynecological Cancer Diagnostics Market Competitive Landscape 30.2. Next-Generation Gynecological Cancer Diagnostics Market Company Profiles 30.2.1. F. Hoffmann-La Roche Ltd. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. AbbVie Inc. 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Novartis AG 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Thermo Fisher Scientific Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Abbott Laboratories 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Next-Generation Gynecological Cancer Diagnostics Market Other Major And Innovative Companies 31.1. Janssen Global Services LLC 31.2. Siemens Healthcare GmbH 31.3. Agena Bioscience Inc. 31.4. Koninklijke Philips N.V. 31.5. Becton, Dickinson and Company 31.6. GE HealthCare Technologies Inc. 31.7. Laboratory Corporation Of America Holdings 31.8. Quest Diagnostics Incorporated 31.9. Agilent Technologies Inc. 31.10. Konica Minolta Inc. 31.11. Hologic Inc. 31.12. Illumina Inc. 31.13. PerkinElmer Inc. 31.14. Sysmex Corporation 31.15. Qiagen N.V. 32. Global Next-Generation Gynecological Cancer Diagnostics Market Competitive Benchmarking 33. Global Next-Generation Gynecological Cancer Diagnostics Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Next-Generation Gynecological Cancer Diagnostics Market 35. Next-Generation Gynecological Cancer Diagnostics Market Future Outlook and Potential Analysis 35.1 Next-Generation Gynecological Cancer Diagnostics Market In 2027 - Countries Offering Most New Opportunities 35.2 Next-Generation Gynecological Cancer Diagnostics Market In 2027 - Segments Offering Most New Opportunities 35.3 Next-Generation Gynecological Cancer Diagnostics Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
The Business Research Company (TBRC)社の医療サービス分野での最新刊レポート
本レポートと同じKEY WORD（ambulatory）の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |
